Sam Chaloub

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF OVERSUBSCRIBED PRIVATE PLACEMENT. COMPANY ISSUES 15,449,829 UNITS AT $0.40 PER UNIT FOR GROSS PROCEEDS OF $6,179,931.60.

Vancouver, BC / February 2, 2021 / BioHarvest Sciences Inc. (the “Company”, or “BioHarvest”) (CSE: BHSC) announces that it has closed its private placement of units at $0.40 per unit previously announced on January 21, 2021. The private placement was oversubscribed by 449,829 units and the Company has determined to accept the oversubscriptions. A total […]

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF OVERSUBSCRIBED PRIVATE PLACEMENT. COMPANY ISSUES 15,449,829 UNITS AT $0.40 PER UNIT FOR GROSS PROCEEDS OF $6,179,931.60. Read More »

BIOHARVEST SCIENCES INC. SHAREHOLDER UPDATE – LIVE EVENT JANUARY 21, 2021 AT 2:00 PM EASTERN STANDARD TIME

Vancouver, BC / January 20, 2021 / BioHarvest Sciences Inc. (the “Company” or “BioHarvest”) (CSE: BHSC) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event

BIOHARVEST SCIENCES INC. SHAREHOLDER UPDATE – LIVE EVENT JANUARY 21, 2021 AT 2:00 PM EASTERN STANDARD TIME Read More »

BIOHARVEST SCIENCES INC. ADDS DR. DENNIS GOODMAN TO ITS RECENTLY CREATED SCIENTIFIC ADVISORY BOARD

Vancouver, BC / January 13, 2021 / BioHarvest Sciences Inc. (the “Company” or “BioHarvest”) (CSE: BHSC) announces that it has created a new board of scientific advisors to assist the Company in capitalizing on its proprietary BioFarming technology. The mandate of the Scientific Advisory Board (“SAB”) is to advise and guide the Company as it

BIOHARVEST SCIENCES INC. ADDS DR. DENNIS GOODMAN TO ITS RECENTLY CREATED SCIENTIFIC ADVISORY BOARD Read More »

BioHarvest Sciences Inc. Exceeds VINIA Israel Sales Orders Expectations for Q4/2020 and Doubles its 2021 Forecast

Vancouver, BC / January 7, 2021. Driven by the high demand in Israel, BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) reports that its Q4 sales orders for VINIA®, the Company’s proprietary red grape cell dietary supplement and functional food, have exceeded the earlier Q4 sales order forecast for the quarter. BioHarvest’s new e-commerce program

BioHarvest Sciences Inc. Exceeds VINIA Israel Sales Orders Expectations for Q4/2020 and Doubles its 2021 Forecast Read More »